Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
LKFT

Market Cap: $1.77B

LN

Lakefront Biotherapeutics N.V.

LKFT

NASDAQ (NASDAQ Global Select)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin94.88%

EBITDA Margin54.67%

EBIT Margin53.84%

Pre-tax Margin58.32%

Net Profit Margin60.23%

Earnings Yield35.03%

Valuation Multiples

Price / Book0.52

Price / Sales1.54

Price / Earnings2.55

PEG0.02

Forward PEG0.34

EV / Sales1.41

EV / EBITDA2.57

EV / Operating Cash Flow-7.23

EV / Free Cash Flow-7.06

Price / Free Cash Flow-7.71

Price / Operating Cash Flow-8.83

Cash Flow & Capital

Free Cash Flow / Share-$2.68

Operating Cash Flow / Share-$2.62

Free Cash Flow Yield-12.96%

Capex / Revenue0.46%

Capex / Operating Cash Flow-2.37%

Capex / Depreciation0.00

Stock Compensation / Revenue0.00%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio32.82

Quick Ratio32.82

Cash Ratio1.93

Debt / Assets0.00

Debt / Capital0.00

Debt / Equity0.00

Long-Term Debt / Capital0.00

Debt / Market Cap0.10%

Net Debt / EBITDA-0.24

Solvency Ratio6.91

Financial Leverage1.03

Efficiency & Working Capital

Asset Turnover0.30

Fixed Asset Turnover0.00

Inventory Turnover0.00

Receivables Turnover17.60

Payables Turnover0.77

Days Sales Outstanding20.73

Days Inventory Outstanding0

Days Payables Outstanding477.08

Operating Cycle20.73

Cash Conversion Cycle-456.35

Working Capital Turnover0.38

Returns & Quality

Return on Equity19.58%

Return on Assets17.81%

Return on Invested Capital18.59%

ROCE18.60%

Return on Tangible Assets22.95%

Operating Return on Assets18.15%

Income Quality-0.32

Tax Burden1.03

Interest Burden1.08

Balance Sheet & Intrinsic Metrics

Enterprise Value$1.39B

Invested Capital$2.99B

Working Capital$2.24B

Tangible Asset Value$2.51B

Net Current Asset Value$2.22B

Graham Number$89.66

Graham Net-Net$29.76

Book Value / Share$44.26

Tangible Book Value / Share$34.08

Cash / Share$30.37

Financial Health Scores

Piotroski Score4

Altman Z-Score12.16

Revenue$990.58M

EBIT$533.37M

Market Cap$1.52B

Working Capital$2.24B

Retained Earnings$233.86M

Total Assets$3.35B

Total Liabilities$87.52M